本文应用 Ea-RFC 试验,观察 TF-S 对经肤酶处理后的人 T 淋巴细胞 E 受体的激活作用,并与人脾转移因子(TF-H)及猪脾转移因子(TF-P)进行比较。结果,TF-S 的 Ea-RFC 平均增高率为101.8%,而 TF-H 及 TF-P 分别为82.0%及91.0%。三种转移因子制剂对人 T 淋巴细胞 Ea-RFC%形成率,经统计学分析,P>0.05,无显著性差异,即 TF-S、TF-H 及 TF-P 对人 T 淋巴细胞 E 受体具有同样的激活作用。研究表明,TF-S 可作为一个新的动物 TF 来源. In this paper, Ea-RFC test was used to observe the activation of E-receptor of human T lymphocytes treated with TF-S, and its interaction with human TF-H and TF- Compare. As a result, the average increase rate of Ea-RFC of TF-S was 101.8%, while TF-H and TF-P were 82.0% and 91.0% respectively. The formation rate of Ea-RFC% of human T lymphocytes by three kinds of transfer factor preparations showed no significant difference by statistical analysis (P> 0.05), that is, the effect of TF-S, TF-H and TF-P on human T lymphocyte E receptor Body has the same activation. Studies have shown that TF-S can be used as a new animal TF source.